公开研究报告

American States Water Company

AWRNYSE

持有

Hold current position with a tightened stop-loss at $87.00, awaiting confirmation from Q3 earnings, FCF improvement, and 10Y yield movement.

AtaiBeckley Inc.

ATAINASDAQ

持有

Hold current position with disciplined risk management: maintain exposure, set stop at $7.10, and take partial profits at $7.45–$7.50.

AtriCure, Inc.

ATRCNASDAQ

减持

Reduce exposure by 30% now; hold remainder with $43.00 stop-loss and wait for pullback confirmation before re-entry.

ARC Group Acquisition I Corp Class A

ARCLNASDAQ

卖出

Sell immediately: ARCL is structurally overvalued with no credible path to close its merger before liquidation.

StoneBridge Acquisition II Corporation Class A

APACNASDAQ

买入

Portfolio Manager’s Final Trading Decision: APAC (StoneBridge Acquisition II Corporation Class A)

Amylyx Pharmaceuticals, Inc.

AMLXNASDAQ

持有

Portfolio Manager’s Final Trading Decision: AMLX

Merck & Co., Inc.

MRKNYSE

持有

Hold current MRK position pending de-risking catalysts such as FDA filing confirmation, REGAL AML data, or commercial launch clarity.

Apogee Acquisition Corp Class A

AACPNASDAQ

持有

Hold current position; await definitive merger announcement or decisive technical breakout above $10.0633 with volume > 100K.

Lam Research Corporation

LRCXNASDAQ

持有

Hold current position in LRCX pending resolution of key catalysts: Q4 earnings (Oct 21), confirmed close above $337.77 on high volume, and stabilization of insider selling.

Applied Materials, Inc.

AMATNASDAQ

持有

Hold current position; await decisive technical confirmation above $520.26 or below $463.49 before adjusting exposure.

Bank of America Corp

BACNYSE

持有

Hold current position in Bank of America Corp (BAC), awaiting resolution of India credit quality and AI project viability before adjusting exposure.

Cisco Systems, Inc.

CSCONASDAQ

持有

Hold current position while awaiting resolution of the core margin–growth tension.

AbbVie, Inc.

ABBVNYSE

持有

Hold current position in ABBV pending resolution of the A-327 FDA decision and confirmation of sustained free cash flow generation.

Johnson & Johnson

JNJNYSE

持有

Hold current position, using $266.00 as a dynamic stop-loss and awaiting Q3 earnings and Monarch adoption data for confirmation.

Mastercard Incorporated Class A

MANYSE

持有

Hold current position in MA; maintain neutral sizing while monitoring $559 support and $599 resistance for directional confirmation.

Exxonmobil Holdings Corporation

XOMNYSE

持有

Maintain current XOM position; no addition or reduction warranted at this time.

Visa Inc. Class A

VNYSE

增持

Overweight Visa (V) gradually across three tranches, using pullbacks as tactical opportunities while respecting near-term resistance and regulatory risk.

Walmart Inc.

WMTNASDAQ

持有

Hold current position; use Q2 earnings on August 20 as the decisive catalyst for Overweight or Underweight action.